featured
Daratumumab Plus Pomalidomide and Dexamethasone vs Pomalidomide and Dexamethasone Alone in Previously Treated Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Daratumumab Plus Pomalidomide and Dexamethasone Versus Pomalidomide and Dexamethasone Alone in Previously Treated Multiple Myeloma (APOLLO): An Open-Label, Randomised, Phase 3 Trial
Lancet Oncol 2021 Jun 01;22(6)801-812, MA Dimopoulos, E Terpos, M Boccadoro, S Delimpasi, M Beksac, E Katodritou, P Moreau, L Baldini, A Symeonidis, J Bila, A Oriol, MV Mateos, H Einsele, I Orfanidis, T Ahmadi, J Ukropec, T Kampfenkel, JM Schecter, Y Qiu, H Amin, J Vermeulen, R Carson, P SonneveldFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.